Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
[
Title
]
Type
Year
Filters:
Author
is
Trneny, Marek
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
C
Kalincik T
,
Sharmin S
,
Roos I
,
Freedman MS
,
Atkins H
,
Burman J
,
Massey J
,
Sutton I
,
Withers B
,
Macdonell R
, et al.
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.
JAMA Neurol. 2023;80(7):702-713.
PubMed
Google Scholar
E
Kalincik T
,
Sharmin S
,
Roos I
,
Massey J
,
Sutton I
,
Withers B
,
Freedman MS
,
Atkins H
,
Krasulova E
,
Havrdova EKubala
, et al.
Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosis.
J Neurol Neurosurg Psychiatry. 2024.
PubMed
Google Scholar
P
Garderet L
,
Sbianchi G
,
Iacobelli S
,
Blaise D
,
Byrne JL
,
Reményi P
,
Apperley JF
,
Touzeau C
,
Isaksson C
,
Browne P
, et al.
Prognostic impact of early-versus-late responses to different induction regimens in patients with myeloma undergoing autologous hematopoietic cell transplantation: results from the CALM study by the CMWP of the EBMT.
Eur J Haematol. 2021.
PubMed
Google Scholar
S
Belada D
,
Kopeckova K
,
Burgues JMiguel Ber
,
Stevens D
,
André M
,
Persona EPerez
,
Pichler P
,
Staber PB
,
Trneny M
,
Duell J
, et al.
Safety and efficacy of tafasitamab ± lenalidomide added to first-line R‑CHOP for DLBCL: Phase 1b First-MIND study.
Blood. 2023.
PubMed
Google Scholar
T
Gagelmann N
,
Eikema D-J
,
Koster L
,
Caillot D
,
Pioltelli P
,
Lleonart JBargay
,
Reményi P
,
Blaise D
,
Schaap N
,
Trneny M
, et al.
Tandem autologous stem cell transplantation improves outcome in newly diagnosed multiple myeloma with extramedullary disease and high-risk cytogenetics: a study from the Chronic Malignancies Working Party of EBMT.
Biol Blood Marrow Transplant. 2019.
PubMed
Google Scholar